Related Experiment Video
Updated: Jun 27, 2026
08:04
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Predictive genomics of cardioembolic stroke
Rachel Badovinac Ramoni1, Blanca E Himes, Michele M Sale
1Harvard-Partners Center for Genetics and Genomics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA. marco_ramoni@harvard.edu
Stroke
|December 10, 2008
Summary
Researchers developed a new model to predict cardioembolic stroke risk. This Bayesian network approach achieved 86% accuracy, significantly outperforming individual genetic markers for stroke prediction.
Area of Science:
- Genetics
- Neurology
- Biostatistics
Background:
- Cardioembolic stroke is a complex condition influenced by multiple factors.
- Accurate prediction of stroke risk is crucial for effective prevention strategies.
Purpose of the Study:
- To develop and evaluate a multivariate predictive model for cardioembolic stroke.
- To assess the performance of Bayesian networks in stroke risk prediction using genetic data.
Main Methods:
- Utilized data from the Genes Affecting Stroke Risk and Outcome Study (GASROS).
- Constructed a multivariate predictive model employing Bayesian networks.
- Evaluated model performance using the area under the receiver operating characteristic curve (AUC).
Main Results:
- The Bayesian network model achieved a predictive accuracy of 86% on fitted values.
- This accuracy significantly surpassed the prognostic performance of individual single nucleotide polymorphisms (SNUs), which had an AUC of 60%.
Conclusions:
- Multivariate predictive models, specifically Bayesian networks, offer a highly accurate approach to predicting cardioembolic stroke.
- This advanced modeling technique demonstrates superior performance compared to single genetic markers in stroke risk assessment.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...